Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mersana Therapeutics Inc.

0.3507
+0.00912.66%
Post-market: 0.3500-0.0007-0.20%19:52 EDT
Volume:1.23M
Turnover:425.33K
Market Cap:43.71M
PE:-0.58
High:0.3552
Open:0.3352
Low:0.3352
Close:0.3416
Loading ...
May 09, 2022

Major Issues Report

8-K - Current report
Apr 14, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 28, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 17, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2022

Major Issues Report

8-K - Current report
Jan 03, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 23, 2021

Major Issues Report

8-K - Current report
Nov 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2021

Major Issues Report

8-K - Current report
Sep 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 10, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Major Issues Report

8-K - Current report